Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-37,175
Closed -$81K 483
2022
Q3
$81K Buy
37,175
+271
+0.7% +$935 0.03% 428
2022
Q2
$129K Buy
36,904
+11,521
+45% +$43K 0.05% 357
2022
Q1
$128K Sell
25,383
-1,500
-6% -$7.6K 0.06% 252
2021
Q4
$169K Buy
26,883
+2,552
+10% +$17.4K 0.06% 292
2021
Q3
$193K Sell
24,331
-1,258
-5% -$10.4K 0.08% 280
2021
Q2
$192K Sell
25,589
-13,328
-34% -$93.1K 0.08% 368
2021
Q1
$235K Buy
38,917
+678
+2% +$5.22K 0.1% 303
2020
Q4
$218K Buy
+38,239
New +$243K 0.09% 337

Other funds holding VXRT

Virtus ETF Advisers's VXRT Position: Q4 2022 in Review

Virtus ETF Advisers sold out of Vaxart (VXRT) in Q4 2022, closing a stake of 37,175 shares — an estimated $81K sold.

Virtus ETF Advisers first reported a position in VXRT in Q4 2020 and held it in 8 quarters. The position peaked at $235K in Q1 2021. 132 funds tracked by Wall St. Rank hold VXRT as of Q4 2022.

  • Virtus ETF Advisers reported no remaining Vaxart position as of Q4 2022 after selling out during the quarter.
  • Virtus ETF Advisers sold 37,175 Vaxart shares in Q4 2022, an estimated $81K.
  • Virtus ETF Advisers first reported a position in Vaxart in Q4 2020 and held it in 8 quarters.
  • Virtus ETF Advisers's Vaxart position peaked at $235K in Q1 2021.
  • 132 funds tracked by Wall St. Rank held Vaxart as of Q4 2022.

Based on Virtus ETF Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.